206 related articles for article (PubMed ID: 23223141)
1. Liver X receptor activation inhibits melanogenesis through the acceleration of ERK-mediated MITF degradation.
Lee CS; Park M; Han J; Lee JH; Bae IH; Choi H; Son ED; Park YH; Lim KM
J Invest Dermatol; 2013 Apr; 133(4):1063-71. PubMed ID: 23223141
[TBL] [Abstract][Full Text] [Related]
2. Emodin isolated from Polygoni Multiflori Ramulus inhibits melanogenesis through the liver X receptor-mediated pathway.
Kim MO; Park YS; Nho YH; Yun SK; Kim Y; Jung E; Paik JK; Kim M; Cho IH; Lee J
Chem Biol Interact; 2016 Apr; 250():78-84. PubMed ID: 26972667
[TBL] [Abstract][Full Text] [Related]
3. A chemical compound from fruit extract of Juglans mandshurica inhibits melanogenesis through p-ERK-associated MITF degradation.
Kim JY; Lee EJ; Ahn Y; Park S; Kim SH; Oh SH
Phytomedicine; 2019 Apr; 57():57-64. PubMed ID: 30668323
[TBL] [Abstract][Full Text] [Related]
4. p44/42 MAPK signaling is a prime target activated by phenylethyl resorcinol in its anti-melanogenic action.
Kang M; Park SH; Park SJ; Oh SW; Yoo JA; Kwon K; Kim J; Yu E; Cho JY; Lee J
Phytomedicine; 2019 May; 58():152877. PubMed ID: 30849679
[TBL] [Abstract][Full Text] [Related]
5. Isoliquiritigenin inhibits melanogenesis, melanocyte dendricity and melanosome transport by regulating ERK-mediated MITF degradation.
Lv J; Fu Y; Cao Y; Jiang S; Yang Y; Song G; Yun C; Gao R
Exp Dermatol; 2020 Feb; 29(2):149-157. PubMed ID: 31785162
[TBL] [Abstract][Full Text] [Related]
6. Tranexamic acid inhibits melanogenesis by activating the autophagy system in cultured melanoma cells.
Cho YH; Park JE; Lim DS; Lee JS
J Dermatol Sci; 2017 Oct; 88(1):96-102. PubMed ID: 28669590
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of melanin synthesis by haginin A and its application to in vivo lightening model.
Kim JH; Baek SH; Kim DH; Choi TY; Yoon TJ; Hwang JS; Kim MR; Kwon HJ; Lee CH
J Invest Dermatol; 2008 May; 128(5):1227-35. PubMed ID: 18037902
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency Irradiation Attenuated UVB-Induced Skin Pigmentation by Modulating ATP Release and CD39 Expression.
Byun KA; Kim HM; Oh S; Son KH; Byun K
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982581
[TBL] [Abstract][Full Text] [Related]
9. Diethylstilbestrol enhances melanogenesis via cAMP-PKA-mediating up-regulation of tyrosinase and MITF in mouse B16 melanoma cells.
Jian D; Jiang D; Su J; Chen W; Hu X; Kuang Y; Xie H; Li J; Chen X
Steroids; 2011 Nov; 76(12):1297-304. PubMed ID: 21745488
[TBL] [Abstract][Full Text] [Related]
10. cAMP-dependent activation of protein kinase A as a therapeutic target of skin hyperpigmentation by diphenylmethylene hydrazinecarbothioamide.
Shin H; Hong SD; Roh E; Jung SH; Cho WJ; Park SH; Yoon DY; Ko SM; Hwang BY; Hong JT; Heo TY; Han SB; Kim Y
Br J Pharmacol; 2015 Jul; 172(13):3434-45. PubMed ID: 25766244
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory Effects of Pinostilbene Hydrate on Melanogenesis in B16F10 Melanoma Cells via ERK and p38 Signaling Pathways.
Chung YC; Hyun CG
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630811
[TBL] [Abstract][Full Text] [Related]
12. Additive effect of heat on the UVB-induced tyrosinase activation and melanogenesis via ERK/p38/MITF pathway in human epidermal melanocytes.
Gu WJ; Ma HJ; Zhao G; Yuan XY; Zhang P; Liu W; Ma LJ; Lei XB
Arch Dermatol Res; 2014 Aug; 306(6):583-90. PubMed ID: 24671267
[TBL] [Abstract][Full Text] [Related]
13. p21-activated kinase 4 critically regulates melanogenesis via activation of the CREB/MITF and β-catenin/MITF pathways.
Yun CY; You ST; Kim JH; Chung JH; Han SB; Shin EY; Kim EG
J Invest Dermatol; 2015 May; 135(5):1385-1394. PubMed ID: 25560280
[TBL] [Abstract][Full Text] [Related]
14. FGF21 regulates melanogenesis in alpaca melanocytes via ERK1/2-mediated MITF downregulation.
Wang R; Chen T; Zhao B; Fan R; Ji K; Yu X; Wang X; Dong C
Biochem Biophys Res Commun; 2017 Aug; 490(2):466-471. PubMed ID: 28623131
[TBL] [Abstract][Full Text] [Related]
15. Activation of the Liver X Receptor by Agonist TO901317 Improves Hepatic Insulin Resistance via Suppressing Reactive Oxygen Species and JNK Pathway.
Dong Y; Gao G; Fan H; Li S; Li X; Liu W
PLoS One; 2015; 10(4):e0124778. PubMed ID: 25909991
[TBL] [Abstract][Full Text] [Related]
16. Stem Cell Factor-Inducible MITF-M Expression in Therapeutics for Acquired Skin Hyperpigmentation.
Yun CY; Roh E; Kim SH; Han J; Lee J; Jung DE; Kim GH; Jung SH; Cho WJ; Han SB; Kim Y
Theranostics; 2020; 10(1):340-352. PubMed ID: 31903124
[No Abstract] [Full Text] [Related]
17. Phytol suppresses melanogenesis through proteasomal degradation of MITF via the ROS-ERK signaling pathway.
Ko GA; Cho SK
Chem Biol Interact; 2018 Apr; 286():132-140. PubMed ID: 29486182
[TBL] [Abstract][Full Text] [Related]
18. Beauvericin inhibits melanogenesis by regulating cAMP/PKA/CREB and LXR-α/p38 MAPK-mediated pathways.
Lee SE; Park SH; Oh SW; Yoo JA; Kwon K; Park SJ; Kim J; Lee HS; Cho JY; Lee J
Sci Rep; 2018 Oct; 8(1):14958. PubMed ID: 30297846
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo studies disclosed the depigmenting effects of gallic acid: a novel skin lightening agent for hyperpigmentary skin diseases.
Kumar KJ; Vani MG; Wang SY; Liao JW; Hsu LS; Yang HL; Hseu YC
Biofactors; 2013; 39(3):259-70. PubMed ID: 23322673
[TBL] [Abstract][Full Text] [Related]
20. JNK suppresses melanogenesis by interfering with CREB-regulated transcription coactivator 3-dependent MITF expression.
Kim JH; Hong AR; Kim YH; Yoo H; Kang SW; Chang SE; Song Y
Theranostics; 2020; 10(9):4017-4029. PubMed ID: 32226536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
